Arachidonic acid-induced human platelet aggregation and prostaglandin formation.
D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002250:Carbon Radioisotopes; D002855:Chromatography, Thin Layer; D003094:Collagen / Q000494:pharmacology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009284:Naphthols / Q000494:pharmacology; D010783:Photometry; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis*; D011817:Rabbits; D011863:Radioimmunoassay; D013268:Stimulation, Chemical
D001095:Arachidonic Acids; D002250:Carbon Radioisotopes; D009284:Naphthols; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000244:Adenosine Diphosphate; D003094:Collagen; D000241:Adenosine; D001241:Aspirin; D004837:Epinephrine